Vivo Capital’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,106,524
Closed -$8.54M 54
2025
Q4
$8.54M Sell
1,106,524
-1,538,461
-58% -$13.7M 0.55% 36
2025
Q3
$23.4M Buy
2,644,985
+1,106,524
+72% +$8.23M 1.88% 17
2025
Q2
$6.38M Hold
1,538,461
0.65% 33
2025
Q1
$9.28M Hold
1,538,461
1.23% 16
2024
Q4
$7.95M Hold
1,538,461
0.89% 26
2024
Q3
$4.6M Hold
1,538,461
0.38% 32
2024
Q2
$4.58M Hold
1,538,461
0.42% 31
2024
Q1
$18.2M Hold
1,538,461
1.43% 17
2023
Q4
$12.5M Hold
1,538,461
1.03% 19
2023
Q3
$12.5M Hold
1,538,461
1.37% 20
2023
Q2
$11.4M Buy
+1,538,461
New +$10.7M 0.79% 21
2020
Q3
Sell
-386,628
Closed -$7.98M 67
2020
Q2
$7.98M Sell
386,628
-291,667
-43% -$7.72M 0.57% 37
2020
Q1
$21.5M Buy
+678,295
New +$17M 1.95% 13

Other funds holding VSTM

Vivo Capital's VSTM Position: Q1 2026 in Review

Vivo Capital sold out of Verastem (VSTM) in Q1 2026, closing a stake of 1,106,524 shares — an estimated $8.54M sold.

Vivo Capital first reported a position in VSTM in Q1 2020 and held it in 13 quarters. The position peaked at $23.4M in Q3 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Vivo Capital reported no remaining Verastem position as of Q1 2026 after selling out during the quarter.
  • Vivo Capital sold 1,106,524 Verastem shares in Q1 2026, an estimated $8.54M.
  • Vivo Capital first reported a position in Verastem in Q1 2020 and held it in 13 quarters.
  • Vivo Capital's Verastem position peaked at $23.4M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.